WaveMan
WaveMan · Company
AQB · Aquabounty Technologies Inc
> Search tickers & screens ⌘K
LIVE
← All companies

AQB Aquabounty Technologies (AQB) Insider Trading, Ownership & Congress Trades

Other · Fishing, hunting and trapping · CIK 0001603978
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
12
13F, latest reported quarter

Aquabounty Technologies insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for AQUABOUNTY TECHNOLOGIES INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
BUY
2022-12-27 SECtraded 2022-12-23
10,000
$8.9K
-91.9%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Dec 22, 2022.
  • -2.5% median (-8.6% mean) 90-day return after 3 previous buys.
  • The trade is 95.9% of the 10,426 shares held after it.
  • 6 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Myers Gail Sharps bought about $8.9K of AQB on Dec 23, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
BUY
2022-12-27 SECtraded 2022-12-22
1
$1
-91.9%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Dec 12, 2022.
  • +4.1% median (+4.1% mean) 90-day return after 2 previous buys.
  • The trade is 0.2% of the 426 shares held after it.
  • 6 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Myers Gail Sharps bought about $1 of AQB on Dec 22, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
BUY
2022-12-21 SECtraded 2022-12-20
10,000
$7.8K
-93.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 10,000 shares held after it.
  • 6 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director St.Clare Christine bought about $7.8K of AQB on Dec 20, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
Director
BUY
2022-12-20 SECtraded 2022-12-19
1,500
$1.1K
-92.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 1,500 shares held after it.
  • 6 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sharp Erin S bought about $1.1K of AQB on Dec 19, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
Director
BUY
2022-12-20 SECtraded 2022-12-19
130,000
$100.1K
-92.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 130,000 shares held after it.
  • 6 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sharp Erin S bought about $100.1K of AQB on Dec 19, 2022, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
67 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 62 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
12 funds bought in last quarter
below 71% of all 58 companies we track
Revenue
-21.2% year over year
below 79% of all 58 companies we track
Margin
-747.8% net margin
the lowest in all 58 companies we track
Buybacks
no share repurchases reported
Short interest
3.6% of the float short (float per yahoo 2026-10-26) · 1.6 days to cover · settled 2026-09-30
more than 68% of all 58 companies we track
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch AQB

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-29.9%12M
-49%-33%-16%+0%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns AQB: institutional holders (13F)

13F holdings, latest reported quarter
$95.2K
$50.9K

Congress trades in AQB

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

AQB planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

AQB mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Extended Market Index Fund
$42.5K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$25.0K position · as of 2026-06-30
0.0%
Fidelity Series Total Market Index Fund
$7.4K position · as of 2026-05-31
0.0%
Blackstone Alternative Multi-Strategy Fund
$214 position · as of 2026-06-30
0.0%
Fidelity Total Market Index Fund
$4.5K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$398.3K
$394.0K
$306.4K
-98%
n/a
2024
$439.8K
$429.2K
$330.9K
-99%
n/a
2023
$496.7K
$440.2K
$371.1K
-93%
n/a
2022
$553.6K
$497.4K
$394.8K
-65%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 12 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

AQB financials

Revenue growth
-21.2%
XBRL, annual
Net margin
-747.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.3M
four quarters, 2023-10-01 to 2024-09-30
Net margin, TTM
-1,458%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$10.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
4.16x
long-term 2026-03-31 plus current 2025-09-30 (9 months older than the period end); equity 2026-06-30
Cash flow to debt
-0.61x
TTM operating cash flow over long-term 2026-03-31 plus current 2025-09-30 (9 months older than the period end)
Return on equity
-223.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-95.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$16.8M
market value at close 2026-10-27 on 2026-08-04 shares, plus long-term 2026-03-31 plus current 2025-09-30 (9 months older than the period end), minus cash 2025-12-31
FCF yield
-181.8%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenuen/an/a$2.5M$3.1M
Operating income-$4.0M-$9.6M-$13.7M-$22.3M
Net income-$18.5M-$149.2M-$27.6M-$22.2M
EPS (diluted)-4.77-38.65-7.17-5.78
Operating cash flow-$8.7M-$13.9M-$24.2M-$21.0M
Cash$501.3K$230.4K$8.2M$101.6M
Long-term debt$3.5M$2.0M$4.5M$6.3M
SEC XBRL, fiscal years, as known on 2026-10-28

AQB Stock Sonar score 5/7 axes

Find similar shapesCompare

AQB ranks highest on risk and compliance (47th percentile) and institutional and government (16th), and lowest on profitability (9th), among Other peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
9
Inputs
  • Return on equity-223.4% · 6 pct, universe of 3,863
  • Return on assets-95.7% · 11 pct, universe of 4,810
  • Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
  • Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
13
Inputs
  • Debt to equity4.16x · 5 pct, universe of 3,589
  • Cash flow to debt-0.61x · 21 pct, universe of 3,315
Growth
13
Inputs
  • Revenue growth, YoY-21.2% · 13 pct, universe of 4,656
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
16
Inputs
  • Funds adding, latest quarter12 · 16 pct, universe of 4,971
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
47
Inputs
  • Short interest, % of float+3.6% · 50 pct, universe of 6,633
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+12.7% · 44 pct, universe of 3,661
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing